Corrado Schiavotto

Erratum: Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

Andrea Gallamini, Corrado Tarella, Simonetta Viviani, Andrea Rossi et autres

High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies

Simonetta Viviani, Anna Vanazzi, Samuele Frassoni, Chiara Rusconi et autres

it (code pays fourni par la source)

Pet-2 Positive during Frontline Therapy: An Early Unfavorable Predictor for Subsequent Salvage High-Dose Chemotherapy (HD-CT) and Autologous Stem Cell Transplant in Relapsed or Refractory Classical Hodgkin Lymphoma

Simonetta Viviani, Anna Vanazzi, Samuele Frassoni, Chiara Rusconi et autres

it (code pays fourni par la source)

Predictive value on advance hodgkin lymphoma treatment outcome of end‐of treatment FDG PET/CT in the HD0607 clinical trial

Alberto Biggi, Stéphane Chauvie, Federico Fallanca, Luca Guerra et autres

it, fr (code pays fourni par la source)

P110: Outcome of high-dose chemotherapy (HDCT) and autologous stem cell transplant (ASCT) as first salvage treatment for relapsed or refractory classical Hodgkin Lymphoma (cHL) in the era of PET-adapted strategy among Italian centers

Simonetta Viviani, Anna Vanazzi, Samuele Frassoni, Chiara Rusconi et autres

it (code pays fourni par la source)

Lesion Dissemination in Baseline PET/CT (D-MAX) and IPS Score Predict ABVD Treatment Outcome in PET-2 Negative Advanced-Stage Hodgkin Lymphoma Patients Enrolled in the Prospective GITIL/FIL HD0607 Trial

Andrea Gallamini, Alessandro Rambaldi, Caterina Patti, Alessandra Romano et autres

fr, it (code pays fourni par la source)

BASELINE METABOLIC TUMOR VOLUME AND IPS PREDICT ABVD FAILURE IN ADVANCED‐STAGE HODGKIN LYMPHOMA WITH A NEGATIVE INTERIM PET SCAN AFTER 2 CHEMOTHERAPY CYCLES. A RETROSPECTIVE ANALYSIS FROM THE GITIL/FIL HD0607 TRIAL

Andrea Gallamini, Alessandro Rambaldi, Caterina Patti, Alessandra Romano et autres

fr, it (code pays fourni par la source)

The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET‐2‐adapted HD0607 trial

Alessandra Romano, Chiara Pavoni, Francesco Di Raimondo, Corrado Tarella et autres

it, fr (code pays fourni par la source)

Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial

Andrea Gallamini, Andrea Rossi, Caterina Patti, Marco Picardi et autres

fr, it (code pays fourni par la source)

CONSOLIDATION RADIOTHERAPY COULD BE OMITTED IN ADVANCED HODGKIN LYMPHOMA WITH LARGE NODAL MASS IN COMPLETE METABOLIC RESPONSE AFTER ABVD. FINAL ANALYSIS OF THE RANDOMIZED HD0607 TRIAL

Andrea Gallamini, Andrea Rossi, Caterina Patti, Marco Picardi et autres

fr, it, il (code pays fourni par la source)

Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) and Lymphocyte to Monocyte Ratio (LMR) in Newly Diagnosed Advanced-Stage Hodgkin Lymphoma Patients Treated up-Front with a PET-2 Risk Adapted Protocol

Alessandra Romano, Francesco Di Raimondo, Chiara Pavoni, Corrado Tarella et autres

it, fr (code pays fourni par la source)

Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL HD 0607 Trial

Andrea Gallamini, Corrado Tarella, Simonetta Viviani, Andrea Rossi et autres

it (code pays fourni par la source)